scholarly journals The Impact of Omega-3 Fatty Acid Use on the Risk of Atrial Fibrillation in Patients with Cardiovascular Disease

2011 ◽  
Vol 02 (01) ◽  
pp. 23-27
Author(s):  
Brian J. Barnes ◽  
Patricia A. Howard ◽  
Scott Solomon ◽  
Warren Chen ◽  
James L. Vacek
Keyword(s):  
Atrial Fibrillation ◽  
Cardiovascular Disease ◽  
Fatty Acid ◽  
Omega 3 ◽  
Omega 3 Fatty Acid ◽  
The Impact

scholarly journals The Omega-3 Fatty Acid Eicosapentaenoic Acid (EPA) Correlates Inversely with Ischemic Brain Infarcts in Patients with Atrial Fibrillation

Nutrients ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 651
Author(s):  
Martin F. Reiner ◽  
Philipp Baumgartner ◽  
Andrea Wiencierz ◽  
Michael Coslovsky ◽  
Nicole R. Bonetti ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Fatty Acid ◽  
Small Vessel Disease ◽  
Small Vessel ◽  
Omega 3 ◽  
Total N ◽  
Ischemic Brain ◽  
Omega 3 Fatty Acid ◽  
Vessel Disease ◽  
Brain Infarcts

The omega-3 fatty acid (n-3 FA) eicosapentaenoic acid (EPA) reduces stroke in patients with atherosclerotic cardiovascular disease. Whether EPA affects stroke or cerebral small vessel dis-ease in patients with atrial fibrillation (AF) remains uncertain. EPA, docosahexaenoic acid (DHA), docosapentaenoic acid (DPA), and alpha-linolenic acid (ALA) were determined by gas chromatography in 1657 AF patients from the Swiss Atrial Fibrillation study. All patients underwent brain MRI to detect ischemic brain infarcts, classified as large noncortical or cortical infarcts (LNCCIs); markers of small vessel disease, classified as small noncortical infarcts (SNCIs), number of microbleeds, and white matter lesion (WML) volumes. Individual and total n-3 FAs (EPA + DHA + DPA + ALA) were correlated with LNCCIs and SNCIs using logistic regression, with numbers of microbleeds using a hurdle model, and WML volumes using linear regression. LNCCIs were detected in 372 patients (22.5%). EPA correlated inversely with the prevalence of LNCCIs (odds ratio [OR] 0.51 per increase of 1 percentage point EPA, 95% confidence interval [CI] 0.29–0.90). DPA correlated with a higher LNCCI prevalence (OR 2.48, 95%CI 1.49–4.13). No associations with LNCCIs were found for DHA, ALA, and total n-3 FAs. Neither individual nor total n-3 FAs correlated with markers of small vessel disease. In conclusion, EPA correlates inversely with the prevalence of ischemic brain infarcts, but not with markers of small vessel disease in patients with AF.

scholarly journals Omega-3 Fatty Acid Supplementation Does Not Reduce Risk of Atrial Fibrillation After Coronary Artery Bypass Surgery

2010 ◽  
Vol 3 (1) ◽  
pp. 46-53 ◽  
Author(s):  
Palaniappan Saravanan ◽  
Ben Bridgewater ◽  
Annette L. West ◽  
Stephen C. O'Neill ◽  
Philip C. Calder ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Fatty Acid ◽  
Coronary Artery ◽  
Coronary Artery Bypass Surgery ◽  
Bypass Surgery ◽  
Artery Bypass ◽  
Omega 3 ◽  
Fatty Acid Supplementation ◽  
Omega 3 Fatty Acid ◽  
Reduce Risk

scholarly journals Omega-3 fatty acid supplementation and cardiovascular disease

2012 ◽  
Vol 53 (12) ◽  
pp. 2525-2545 ◽  
Author(s):  
Donald B. Jump ◽  
Christopher M. Depner ◽  
Sasmita Tripathy
Keyword(s):  
Cardiovascular Disease ◽  
Fatty Acid ◽  
Omega 3 ◽  
Fatty Acid Supplementation ◽  
Acid Supplementation ◽  
Omega 3 Fatty Acid

scholarly journals The impact of an omega-3 fatty acid rich lipid emulsion on fatty acid profiles in critically ill septic patients

2016 ◽  
Vol 112 ◽  
pp. 1-11 ◽  
Author(s):  
Thomas C. Hall ◽  
Dilraj K. Bilku ◽  
Christopher P. Neal ◽  
Jill Cooke ◽  
Helena L. Fisk ◽  
...  
Keyword(s):  
Fatty Acid ◽  
Critically Ill ◽  
Lipid Emulsion ◽  
Fatty Acid Profiles ◽  
Omega 3 ◽  
Omega 3 Fatty Acid ◽  
The Impact
Sign in / Sign up

Export Citation Format

Share Document